Key Insights

Highlights

Treatment Research

1 treatments under study, led by Azd2936

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05414032Phase 2RecruitingPrimary

Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCC

Showing all 1 trials

Research Network

Common Treatments

  • Azd29361

Active Sponsors

  • Personalis Inc.1
  • AstraZeneca1
  • University Health Network, Toronto1
  • NeoGenomics Laboratories, Inc.1

Top Investigators

Activity Timeline